Your session is about to expire
← Back to Search
68Ga-DOTATATE PET/CT Scan for Neuroblastoma
Study Summary
This trial studies a new scan to diagnose neuroendocrine tumors in children. The new scan, 68Ga-DOTATATE PET/CT, may work better than the standard of care MIBG scan.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am scheduled for radiation therapy at the institution where I am enrolling.My neuroblastoma is high-risk and needs additional radiation therapy.My cancer is confirmed as neuroblastoma, ganglioneuroblastoma, or ganglioneuroma.I am 30 years old or younger.I am HIV positive but not immunocompromised, or I am on antiretroviral therapy.I can care for myself but may not be able to do heavy physical work.
- Group 1: Cohort B (68Ga-DOTATATE, PET/CT)
- Group 2: Cohort A (68Ga-DOTATATE, PET/CT)
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being admitted into this clinical trial?
"Affirmative, the clinicaltrials.gov website indicates that this trial is still enrolling volunteers. This project was first made available on September 23rd 2019 and last revised on October 11th 2022. In total, 20 individuals must be sourced from two different centres."
Is there presently an opportunity for individuals to become involved in this research endeavor?
"Confirmed, the trial is still open to participants. This medical research was initially posted on September 23rd 2019 and then updated on October 11th 2022 according to clinicaltrials.gov records."
Has there been prior research into the efficacy of Gallium Ga 68-DOTATATE?
"Currently, 18 trials are investigating the efficacy of Gallium Ga 68-DOTATATE with none yet in Phase 3. These studies span 51 sites, one of which is located Bethesda Maryland."
Share this study with friends
Copy Link
Messenger